- Home
- MRNA vs AKAM Comparison
MRNA vs AKAM Comparison
Compare MRNA & AKAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | AKAM |
|---|---|---|
| Founded | 2010 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 11.4B |
| IPO Year | 2018 | 1999 |
Fundamental Metrics
Financial Performance| Metric | MRNA | AKAM |
|---|---|---|
| Price | $27.57 | $83.41 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 13 | 16 |
| Target Price | $33.91 | ★ $91.20 |
| AVG Volume (30 Days) | ★ 9.9M | 4.6M |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 0.97 |
| EPS | N/A | ★ 3.41 |
| Revenue | $2,232,000,000.00 | ★ $4,133,202,000.00 |
| Revenue This Year | N/A | $7.09 |
| Revenue Next Year | $0.77 | $5.26 |
| P/E Ratio | ★ N/A | $24.46 |
| Revenue Growth | N/A | ★ 4.21 |
| 52 Week Low | $22.28 | $67.51 |
| 52 Week High | $48.92 | $103.75 |
Technical Indicators
Market Signals| Indicator | MRNA | AKAM |
|---|---|---|
| Relative Strength Index (RSI) | 60.85 | 46.48 |
| Support Level | $23.92 | $86.06 |
| Resistance Level | $26.00 | $88.47 |
| Average True Range (ATR) | 1.29 | 2.31 |
| MACD | 0.32 | -0.82 |
| Stochastic Oscillator | 99.82 | 8.43 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About AKAM Akamai Technologies Inc.
Akamai operates a content delivery network, which entails locating servers at the edges of networks so its customers, which store content on Akamai servers, can reach their own customers faster, more securely, and with better quality. Akamai has over 325,000 servers distributed over 4,100 points of presence in more than 1,000 cities worldwide. The firm also offers security and cloud computing for its customers, and those businesses have grown to be bigger than the legacy CDN.